Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_assertion type Assertion NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_head.
- NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_assertion description "[Importantly, LATS1 signaling was disrupted by 17-AAG in tumor cell lines in vitro and clinical ovarian cancers in vivo as shown by reduced levels of LATS1 and decreased phosphorylation of the LATS substrate YAP, an oncoprotein transcriptional coactivator that regulates genes involved in cell and tissue growth, including the CTGF gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_provenance.
- NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_assertion evidence source_evidence_literature NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_provenance.
- NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_assertion SIO_000772 20841485 NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_provenance.
- NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_assertion wasDerivedFrom befree-2016 NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_provenance.
- NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_assertion wasGeneratedBy ECO_0000203 NP839121.RAVnX-JZOAHHNIsU5SNIE_QbgvHpbwpbsk5Us1zhRxmTk130_provenance.